NIH-funded research R01 grant

Improving wound healing through advanced tissue engineering techniques

Official title: Vasculogenic Regenerative Medicine Technology

Funded at University of Pittsburgh at Pittsburgh · NIH-11021358 · Data updated 2026-11-12

This study is exploring a new way to help wounds heal faster by using a special technique to turn skin cells into ones that can help grow new blood vessels right at the injury site, which could lead to better recovery for patients with acute wounds.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startDecember 10, 2024
Project endNovember 30, 2028
Funding year2025
Award (this year)$543,826
NIH project number1R01DK141513-01
Project IDNIH-11021358 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with acute wounds that are experiencing delayed healing.

Less likely to help

Patients with chronic wounds or those not responding to standard wound care may not benefit from this research.

What this research studies

This research investigates innovative methods to enhance wound healing by utilizing a technique called tissue nanotransfection (TNT) to convert skin fibroblasts into vasculogenic fibroblasts. By applying specific transcription factors, the study aims to promote the formation of new blood vessels directly at the wound site, potentially improving recovery from acute wounds. The approach focuses on understanding the biological processes that enable this transformation and how it can be effectively applied in vivo. Patients may benefit from improved healing outcomes through this advanced regenerative medicine technology.

Why it matters

Potential benefit: If successful, this research could lead to faster and more effective healing of acute wounds, reducing complications and improving quality of life for patients.

How similar studies have gone: Previous studies have shown promising results using similar tissue engineering approaches, indicating potential for success in this novel application.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Sen, Chandan K — University of Pittsburgh at Pittsburgh
  • Study coordinator: Sen, Chandan K

Related research

Other NIH-funded projects on the same topics.

  • Elastomeric membranes for safer pelvic organ prolapse repair

    A new 3D-printed elastomeric membrane made from polycarbonate urethane is being tested to replace stiff polypropylene meshes for pelvic organ prolapse in women, aiming to reduce complications.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11668074

  • Role of hyaluronan in egg development and ovarian reserve

    This grant studies how the hyaluronan matrix in the ovary affects the aging of the female reproductive system and the pool of eggs available.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11668041

  • Regulatory switches that control imprinting in early human development

    This grant studies how certain genes stay “one-copy” active in early development and what goes wrong in assisted reproduction, with a focus on imprinting disorders.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11668004

  • Identifying molecular signs of imprinting errors linked to fertility treatments

    This grant studies how assisted reproductive technologies may cause imprinting errors in embryos and how these errors relate to certain birth conditions, with implications for families using infertility treatments.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11667742

  • Bioadhesive vaginal film for 7-day protection against HIV, HSV, and pregnancy

    A vaginal film that slowly releases antibodies to prevent HIV, HSV, and unintended pregnancy for about a week from a single use.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11645331

  • Spermatogonial stem cell transplantation and culture in patients

    Researchers are testing a way to transplant or grow sperm-producing cells back in boys and men who stored tissue before cancer treatment, to help them have biological children in the future.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11645297

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.